Global DNA Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $23.1 Billion as Gene Therapy and Synthetic Biology Drive 17.8% CAGR

Global DNA Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $23.1 Billion as Gene Therapy and Synthetic Biology Drive 17.8% CAGR Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "DNA Manufacturing Market Size, Share & Trends Analysis Report by Type, Grade, Application, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global DNA manufacturing market was valued at an estimated USD 6.4 billion in 2025 and is projected to reach USD 23.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 17.8% from 2026 to 2033. Rising demand for gene therapies, personalized medicine, synthetic biology, pharmaceutical research, and vaccine development is supporting sustained market growth.

Advances in DNA synthesis technologies are improving production speed, precision, scalability, and quality. In July 2024, GenScript Biotech announced an advanced DNA synthesis platform designed to reduce production time and accelerate the development of gene therapies and synthetic vaccines. Continued investment in rapid synthesis platforms is expected to strengthen DNA manufacturing capacity across research and clinical applications.

Gene Therapy Demand Accelerates DNA Manufacturing

The growing gene therapy pipeline is creating substantial demand for high-quality plasmid DNA, synthetic DNA, gene synthesis, and oligonucleotide synthesis. As treatments for genetic disorders, rare diseases, and chronic conditions progress through clinical development and regulatory review, manufacturers must produce increasingly complex and customized DNA sequences at scale.

In September 2022, GenScript USA Inc. introduced its GenWand Double-Stranded DNA (dsDNA) service to support CRISPR-based gene editing in T-cell engineering. The service provides covalently closed, linear DNA templates developed to improve homology-directed repair efficiency and reduce off-target effects compared with traditional PCR-based methods.

NewBiologix expanded gene therapy manufacturing capabilities in November 2024 with the launch of its Xcell rAAV Production and Analytics Platform. The platform supports simultaneous screening of multiple rAAV candidates and delivers data for preclinical and clinical development. Its analytical capabilities include assessments of full and empty capsid ratios, encapsulated DNA, and gene sequence integrity.

Successful gene therapy applications in spinal muscular atrophy, inherited blindness, beta-thalassemia, and other serious conditions are further increasing the need for reliable DNA manufacturing. Therapeutic developers require large-scale production of precise and pure DNA sequences for viral vectors, plasmids, and other delivery systems.

Automation and Grade Improvements Transform Production

Automation, silicon-based DNA synthesis, microfluidics, AI-powered design tools, sequencing technologies, and bioinformatics are reshaping the global DNA manufacturing market. These technologies enable high-throughput production while improving accuracy, reproducibility, turnaround times, and cost efficiency.

In November 2023, Twist Bioscience launched Express Genes, a rapid gene synthesis service capable of delivering NGS-verified clonal genes within five to seven days. The service uses the company's silicon-based platform and expanded manufacturing capacity to meet demand for faster research workflows.

In March 2025, WuXi Biologics introduced the EffiX platform, an E. coli-based system developed to improve recombinant protein and plasmid DNA production. The platform offers high yield, stability, scalability, and cost-efficient manufacturing across multiple biologics modalities. Together with enhanced sequencing and bioinformatics tools, these innovations are strengthening quality control for R&D Grade and GMP Grade DNA products.

Global DNA Manufacturing Market Segmentation

The report analyzes revenue growth, market trends, competitive developments, and opportunities from 2021 to 2033. The global DNA manufacturing market is segmented by type, grade, application, end use, and region.

Type Outlook (Revenue, USD Million, 2021-2033)

Grade Outlook (Revenue, USD Million, 2021-2033)

Application Outlook (Revenue, USD Million, 2021-2033)

End Use Outlook (Revenue, USD Million, 2021-2033)

Regional Outlook (Revenue, USD Million, 2021-2033)

Report Benefits

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.2.1. Type

1.2.2. Grade

1.2.3. Application

1.2.4. End Use

1.3. Information Analysis

1.4. Information Procurement

1.4.1. Primary Research

1.5. Market Formulation & Data Visualization

1.6. Data Validation & Publishing

1.7. Market Model

1.8. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.2.3. Market Challenges Analysis

3.2.4. Market Opportunity Analysis

3.3. Case Study Insights

3.4. DNA Manufacturing Market Analysis Tools

3.4.1. Industry Analysis - Porter's Five Forces Analysis

3.4.2. PESTEL Analysis

Chapter 4. DNA Manufacturing Market: Type Business Analysis

4.1. Type Segment Dashboard

4.2. Global DNA Manufacturing Market Type Movement Analysis

4.3. Global DNA Manufacturing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)

4.4. Plasmid DNA

4.4.1. Global Plasmid DNA Market, 2021-2033 (USD Million)

4.5. Synthetic DNA

4.5.1. Global Synthetic DNA Market, 2021-2033 (USD Million)

Chapter 5. DNA Manufacturing Market: Grade Business Analysis

5.1. Grade Segment Dashboard

5.2. Global DNA Manufacturing Market Grade Movement Analysis

5.3. Global DNA Manufacturing Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)

5.4. GMP Grade

5.4.1. Global GMP Grade Market, 2021-2033 (USD Million)

5.5. R&D Grade

5.5.1. Global R&D Grade Market, 2021-2033 (USD Million)

Chapter 6. DNA Manufacturing Market: Application Business Analysis

6.1. Application Segment Dashboard

6.2. Global DNA Manufacturing Market Application Movement Analysis

6.3. Global DNA Manufacturing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

6.4. Cell & Gene Therapy

6.4.1. Global Cell & Gene Therapy Market, 2021-2033 (USD Million)

6.5. Vaccines

6.5.1. Global Vaccines Market, 2021-2033 (USD Million)

6.6. Oligonucleotide-based Drugs

6.6.1. Global Oligonucleotide-based Drugs Market, 2021-2033 (USD Million)

6.7. Others

6.7.1. Global Others Market, 2021-2033 (USD Million)

Chapter 7. DNA Manufacturing Market: End Use Business Analysis

7.1. End Use Segment Dashboard

7.2. Global DNA Manufacturing Market End Use Movement Analysis

7.3. Global DNA Manufacturing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)

7.4. Pharmaceutical and Biotechnology Companies

7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2021-2033 (USD Million)

7.5. Academic & Research Institutes

7.5.1. Global Academic & Research Institutes Market, 2021-2033 (USD Million)

7.6. Contract Research Organizations

7.6.1. Global Contract Research Organizations Market, 2021-2033 (USD Million)

Chapter 8. Regional DNA Manufacturing Market: Region Estimates & Trend Analysis

8.1. North America

8.1.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)

8.1.2. U.S.

8.1.3. Canada

8.1.4. Mexico

8.2. Europe

8.2.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)

8.2.2. UK

8.2.3. Germany

8.2.4. France

8.2.5. Italy

8.2.6. Spain

8.2.7. Norway

8.2.8. Sweden

8.2.9. Denmark

8.3. Asia-Pacific

8.3.1. Asia-Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)

8.3.2. Japan

8.3.3. China

8.3.4. India

8.3.5. Thailand

8.3.6. South Korea

8.3.7. Australia

8.4. Latin America

8.4.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)

8.4.2. Brazil

8.4.3. Argentina

8.5. Middle East & Africa

8.5.1. Middle East & Africa Market Estimates and Forecasts, 2021-2033 (USD Million)

8.5.2. South Africa

8.5.3. Saudi Arabia

8.5.4. UAE

8.5.5. Kuwait

Chapter 9. Competitive Landscape

9.1. Company Categorization

9.2. Strategy Mapping

9.3. Company Market Position Analysis, 2025

9.4. Company Profiles/Listing

9.4.1. Charles River Laboratories, Inc.

9.4.2. VGXI, Inc.

9.4.3. Danaher Corporation (Aldevron)

9.4.4. Thermo Fisher Scientific Inc.

9.4.5. Lonza

9.4.6. GenScript

9.4.7. Catalent, Inc.

9.4.8. Wuxi AppTec

9.4.9. Kaneka Corp.

9.4.10. Eurofins Genomics

List of Tables [124]

List of Figures [62]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/5wucqg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.